ACS applied bio materials

Making Antibody-Modified mRNA Nanoparticles Using Two Post-Loading Methods

Updated

Abstract

Modification of lipid nanoparticles can significantly improve the targeting of T cells by enhancing the accumulation of antibody-modified mRNA-lipid nanoparticles.

  • Ligand-modified lipid nanoparticles (LNPs) can effectively deliver messenger RNA (mRNA) to specific tissues or cells.
  • Using T-cell-targeting models shows that targeting efficacy is influenced by the surface characteristics of the LNPs.
  • Modification of the lipid components, such as DSPE-PEG-methoxy and the use of DSPC or DPPC, is associated with enhanced accumulation in T cells.
  • A seamless production strategy for antibody-modified mRNA-LNPs integrates mRNA encapsulation with ligand-conjugated lipid insertion.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free